Biosimilars: Navigating Regulatory Landscapes, Market Dynamics, and the Pursuit of Enhanced Biotherapeutic Accessibility
Abstract Biosimilars, as near copies of originator biologic drugs, hold the potential to significantly reduce healthcare costs and improve patient access to life-saving therapies. This research report provides a comprehensive analysis of biosimilars, encompassing regulatory […]
